Patients with type 2 diabetes and their clinicians may not share the same priorities when it comes to choosing a second-line drug after metformin, new research suggested.
CU Anschutz
Fitzsimons Building
13001 East 17th Place
Aurora, CO 80045
Are You Giving Your Patients With T2D the Meds They Want?
Default sub title
minute read
by Medscape | February 5, 2024
